ENTITY
Hangzhou Tigermed Consulting C

Hangzhou Tigermed Consulting C (3347 HK)

107
Analysis
Health CareChina
Hangzhou Tigermed Consulting Co.,Ltd. provides professional clinical research services for domestic and foreign pharmaceutical and health-related research and development. The Company's main services include clinical trial technology services, data management, and statistical analysis. Hangzhou Tigermed Consulting offers services worldwide.
more
Refresh
25 Oct 2023 08:31

Midea A/H Listing - Early Look - Probably Raising Acquisition Currency

Midea officially filed for an H-share listing yesterday. As per media reports the company is looking to raise up to US$3bn in Hong Kong.

Logo
894 Views
Share
17 Jul 2023 17:17

Joinn Laboratories (6127.HK) - Concerns Begin to Arise when the Monkeys Become More Expensive

Joinn is the company with the strongest cyclical attribute in CXO sector, mainly because its performance growth is closely related with changes in...

Logo
483 Views
Share
15 Aug 2024 09:44

Midea A/H Listing - Getting Closer to the US$3bn+ Raising, Has a Narrow Window

Midea Group Co Ltd A (000333 CH) one of the world’s largest home appliance producers, aims to raise up to US$3bn in its H-share listing. In this...

Logo
333 Views
Share
02 Aug 2024 11:02

Hong Kong Connect Flows (July): 11 Months of Inflows

We analyzed the Hong Kong Connect Scheme for July and highlighted inflows into ICBC, Tencent, CCB, Yankuang, Sinopec, and outflows from HSBC,...

Logo
355 Views
Share
bearishRemegen
14 Jul 2024 09:26

China Healthcare Weekly (July.14) - CXO's Disputed Business Model, Remegen Shares Plunged, Kelun Bio

​China CXOs prioritize investment over R&D, leading to potential conflicts of interest. Investors challenged RemeGen due to poor outlook. After...

Logo
380 Views
Share
x